Religare Enterprises Limited will host an earnings call on August 13, 2026, to discuss its operational and financial performance for the quarter ended June 30, 2026. The announcement provides investors and analysts with an opportunity to review the company’s results for Q1FY27 directly with management. This disclosure ensures transparency regarding the firm’s recent financial standing ahead of broader market analysis.

The notice was issued pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Babu Rao P., Group General Counsel & Group Chief Compliance Officer, signed the communication dated August 07, 2026. The filing was submitted to both the National Stock Exchange of India Ltd and BSE Limited.

Call Details

The earnings call is scheduled for Thursday, August 13, 2026, at 04:00 PM IST. Participants are required to pre-register using the link provided in the invitation. The management team of Religare and its subsidiaries will be available to address queries.

RSVP and Contact Information

Investors requiring assistance or further details may contact Adfactors PR Private Ltd. Ms. Hanishi Shah is the designated point of contact, reachable via email at teamreligare@adfactorspr.com .

Religare Enterprises Limited’s registered office is located at First Floor, Office No. 101, 2E/23, Jhandewalan Extn., New Delhi – 110055. The corporate office operates from 1st Floor, Tower A, Club 125, Plot A-3,4, 5, Sector -125, Noida – 201301, Uttar Pradesh.

The Reserve Bank of India (RBI) has rejected the no-objection request for the proposed demerger scheme between Religare Enterprises and Religare Finvest Limited, dealing a significant setback to the restructuring plan. This regulatory hurdle halts the transfer of the demerged undertaking from Religare Enterprises to its subsidiary, Religare Finvest, despite earlier approvals from key market regulators. The rejection underscores the stringent scrutiny applied by the central bank to corporate restructuring involving financial entities.

The development follows a series of procedural milestones achieved earlier in the year. On February 14, 2026, the Board of Directors of Religare Enterprises approved the Scheme of Arrangement, subject to receiving requisite regulatory and statutory approvals. Subsequently, on July 7, 2026, the company disclosed that it had received 'no objection' letters from the National Stock Exchange of India Limited and 'no adverse observations' from BSE Limited regarding the scheme. These positive responses from the stock exchanges had paved the way for the final regulatory clearances needed to proceed with the demerger.

However, the RBI's communication changes the trajectory of the deal. Religare Enterprises received a letter dated August 6, 2026, from the Reserve Bank of India stating that after examination, the application for no-objection/prior approval had not been acceded to. Similarly, Religare Finvest received a communication dated August 7, 2026, conveying the same decision. The Scheme involves the transfer of the Demerged Undertaking of Religare Enterprises to Religare Finvest pursuant to Sections 230 to 232 read with Section 52, Section 66, and other applicable provisions of the Companies Act, 2013.

Regulatory Timeline

The following table summarises the key regulatory milestones in the demerger process:

Regulatory Context and Next Steps

The rejection comes under the purview of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. The company has disclosed this development under Regulation 30 of the SEBI LODR Regulations. According to the intimation filed with the stock exchanges, both Religare Enterprises and Religare Finvest intend to engage with the regulator to provide further clarifications as may be required. This indicates that the companies are exploring avenues to address the RBI's concerns, although the timeline for any potential resolution remains uncertain.

The failure of the RBI to grant its no-objection is a critical block in the implementation of the scheme. Without this clearance, the legal transfer of assets and liabilities as outlined in the Scheme cannot proceed. Investors and stakeholders will now be watching closely to see how the management responds to the regulator's stance and whether additional information or structural changes can secure the necessary approval.